StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3029% above fair value
$515.02−5.64 (-1.08%)

Close on Nov 20, 2026Market cap $130.54BP/E 30.0Yield –

Vertex Pharmaceuticals Common shares outstanding at period-end (M) by Quarter

Common shares outstanding at period-end (M) (M)

Vertex Pharmaceuticals Common shares outstanding at period-end (M): 253M in Q2 2026, down 1.2% from a year earlier.

Latest, Q2 2026
253
Period ended Jun 30, 2026
Change on a year earlier
-1.2%
256 in Q2 2025
History
66 quarters
Since Q4 2009
Sources
62
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-04) ↗

Reported in Form 10-Q / 10-K (DB).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCommon shares outstanding at period-end (M) (M)Year on yearSource
Q2 2026Jun 30, 2026253-1.2%Form 10-Q (filed 2026-08-04) ↗
Q1 2026Mar 31, 2026254-1.1%Form 10-Q (filed 2026-05-05) ↗
Q4 2025Dec 31, 2025254-1.1%Form 10-K (filed 2026-02-13) ↗
Q3 2025Sep 30, 2025254-1.4%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 2025256-0.7%Form 10-Q (filed 2025-08-05) ↗
Q1 2025Mar 31, 2025257-0.5%Form 10-Q (filed 2025-05-06) ↗
Q4 2024Dec 31, 2024257-0.3%Form 10-K (filed 2025-02-13) ↗
Q3 2024Sep 30, 20242580.0%Form 10-Q (filed 2024-11-05) ↗
Q2 2024Jun 30, 2024258+0.1%Form 10-Q (filed 2024-08-02) ↗
Q1 2024Mar 31, 2024258+0.3%Form 10-Q (filed 2024-05-07) ↗
Q4 2023Dec 31, 2023258+0.3%Form 10-K (filed 2024-02-15) ↗
Q3 2023Sep 30, 2023258+0.5%Form 10-Q (filed 2023-11-07) ↗
Q2 2023Jun 30, 2023258+0.7%Form 10-Q (filed 2023-08-02) ↗
Q1 2023Mar 31, 2023258+0.7%Form 10-Q (filed 2023-05-02) ↗
Q4 2022Dec 31, 2022257+1.0%Form 10-K (filed 2023-02-10) ↗
Q3 2022Sep 30, 2022257+0.2%Form 10-Q (filed 2022-10-28) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Common shares outstanding at period-end (M) (M), quarterly Q4 2009–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/fs-sh-out

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.

See a number that looks wrong?